Overview

Heparin vs Placebo for Cardiac Catheterization

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:
0

Participant gender:
All

Summary

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Lawson Health Research Institute

Treatments:

Heparin

Criteria

Inclusion Criteria:

- diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar
circulation

Exclusion Criteria:

abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to
the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin;
Patients requiring anticoagulation